newsfilter.io

Nick Leschly

Showing 11 of 1 transcripts.

  1. Goldman Sachs10 min

    Talks at GS – Nick Leschly: The Promise of Gene Therapy

    Nick Leschly

    Bluebird Bio is applying a gene-editing strategy to treat genetic diseases like sickle cell disease and cancer by harvesting patient stem cells, inserting functional DNA via viral vectors, and reinfusing the modified cells to achieve a permanent cure. Led by CEO Nick Lashley, the company has overcome a history of industry overpromising by adopting a strictly patient-centric culture that enforces operational frugality and high executive autonomy to ensure focus on therapeutic efficacy. Early clinical results demonstrate the therapy's potential, with treated sickle cell patients reportedly free of pain medication within six months, validating the firm's shift toward "function engineering" rather than simple restoration.